“Greatness is not a function of circumstance. Greatness, it turns out, is largely a matter of conscious choice, and discipline.” ― James C. Collins, Good to Great: Why Some Companies Make the Leap… and Others Don’t
Good to Great was published back in 2001; however, I believe the quote above still serves as an overall guide for marketing organizations’ need to create innovation in
So, where are we now?
I recently have spoken with a few industry leaders at pharmaceutical industry conferences and inevitably they ask “Neil, how can I re-organize the way we do business to maximize my Multichannel and content marketing strategy?” This conversation inevitably leads to a series of
ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit https://www.evaluate.com/vantage/articles/events/conferences/esc-2020-jardiance-joins-farxiga-showing-heart-failure-benefit
Nestlé agrees $2.6bn deal for Aimmune Therapeutics https://www.ft.com/content/355c51ae-650f-4ee3-8742-bfd3fef0dbc2?segmentid=acee4131-99c2-09d3-a635-873e61754ec6
Why Novavax's Coronavirus Vaccine Might Be First to Market @themotleyfool #stocks $NVAX $PFE $JNJ $AZN $MRNA https://www.fool.com/investing/2020/08/28/why-novavaxs-coronavirus-vaccine-might-be-first-to/
Takeda inks up to $500M collaboration with extra-cellular matrix biotech for NASH - https://endpts.com/takeda-inks-up-to-500m-extra-cellular-matrix-biotech-for-nash/
